Annual Research Day 5 May 2017

Session 1

Completed study results and updates

  • Contraceptive Hormone Induced Changes: Final results – Mr A. Matubu:-  ZimCHIC-Study Results

  • Long Acting Injectable Rilpivirine Is Safe & Acceptable for HIV Prevention –  Dr N. Mgodi:- HPTN-076 Results
  • Genotype-directed dosing for Efavirenz – Dr T. Mbengeranwa:- P1070- Results
  • R.E.A.L.I.T.Y. study results – Dr G. Musoro:- REALITY Study Results
  • Safer Conception Strategies for HIV sero-discordant couples – Dr B. Mateveke:- SAFER Study

Session 2

Opening ceremony

  • Welcome Remarks – Prof Z.M. Chirenje UZ-UCSF Executive Director
  • Official Opening – Prof M. Chidzonga, Dean UZCHS
  • Introducing Guest of Honour – Prof M. Mbizvo
  • Keynote address: Population-based HIV Impact Assessments (PHIAs) – Dr J.E. Justman: PHIA Project 3 country summary

Session 3

Updates on Immune approaches and Pre-Exposure Prophylaxis 

Session 4

TB and ART for cure

Website by Canton Becker